CVET logo

Covetrus, Inc. Stock Price

NasdaqGM:CVET Community·US$2.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

CVET Share Price Performance

US$0
0.00 (0.00%)
US$0
0.00 (0.00%)
Price US$0

CVET Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Good value with adequate balance sheet.

1 Risk
1 Reward

Covetrus, Inc. Key Details

US$4.6b

Revenue

US$3.8b

Cost of Revenue

US$882.0m

Gross Profit

US$895.0m

Other Expenses

-US$13.0m

Earnings

Last Reported Earnings
Jun 30, 2022
Next Reporting Earnings
n/a
-0.093
18.97%
-0.28%
68.7%
View Full Analysis

About CVET

Founded
2018
Employees
4873
CEO
Benjamin Wolin
WebsiteView website
www.covetrus.com

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. As of October 13, 2022, Covetrus, Inc. was taken private.

Recent CVET News & Updates

Is Covetrus (NASDAQ:CVET) Using Too Much Debt?

May 05
Is Covetrus (NASDAQ:CVET) Using Too Much Debt?

Recent updates

No updates